Bicara Appoints Bender, Oliger to Board
Bicara Therapeutics announced the appointment of Jeremy Bender and Christy Oliger to its board. The company also confirmed the retirement of founding director Kiran Mazumdar-Shaw.
View filing at SEC.gov →2 most recent filings and news items mentioning BCAX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/BCAX/news?limit=20"
Pull BCAX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayBicara Therapeutics announced the appointment of Jeremy Bender and Christy Oliger to its board. The company also confirmed the retirement of founding director Kiran Mazumdar-Shaw.
View filing at SEC.gov →Bicara's ficerafusp alfa plus pembrolizumab demonstrated approximately doubled overall survival compared to standard of care in first-line recurrent/metastatic HPV-negative head and neck cancer at three-year follow-up. The company is advancing the 1500mg weekly dose in its Phase
View filing at SEC.gov →